Author

K. Atanasoff

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:proteomics· 2 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1

Frequent Co-Authors

A. Garcia-Sastre· 1 shared A. Raskin· 1 shared A. S. Moghaddam· 1 shared A. Singh· 1 shared B. Lee· 1 shared C. I. Pai· 1 shared C. Powers· 1 shared D. Bresson· 1 shared

Activity by Year

2022-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Garcia-Sastre

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Quantifying and controlling the proteolytic degradation of cell adhesion peptides

S. J. Rozans, A. S. Moghaddam, Y. Wu, K. Atanasoff, L. Nino, K. Dunne, E. T. Pashuck

This study quantifies non-specific proteolytic degradation of cell adhesion peptides and shows that terminal modifications can reduce degradation in different cell types and matrices.

bioRxiv · Apr 19, 2024 · PreprintBioengineering

Discovery of a SARS-CoV-2 Broadly-Acting Neutralizing Antibody with Activity against Omicron and Omicron + R346K Variants

J. A. Duty, T. A. Kraus, H. Zhou, Y. Zhang, N. Shaabani, S. Yildiz, N. Du, A. Singh, L. Miorin, D. Li, K. Stegman, S. I. Ophir, X. Cao, K. Atanasoff, R. Lim, , R. Allen

This paper identifies a broadly neutralizing antibody, STI-9167, effective against SARS-CoV-2 variants including Omicron and Omicron + R346K, and describes its development for clinical trials.

bioRxiv · Jan 19, 2022 · PreprintMicrobiology